Shuttle Pharmaceuticals Files 8-K for Material Agreement
Ticker: SHPH · Form: 8-K · Filed: Sep 22, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Sep 22, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001, $1,450,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
Related Tickers: SHPH
TL;DR
Shuttle Pharma (SHPH) filed an 8-K for a material agreement on 9/15. Keep an eye on this.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on September 22, 2025, reporting a material definitive agreement entered into on September 15, 2025. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
This filing indicates a significant business development for Shuttle Pharmaceuticals, potentially impacting its operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's stock price.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- September 15, 2025 (date) — Date of earliest event reported
- September 22, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Address of principal executive offices
FAQ
What type of material definitive agreement did Shuttle Pharmaceuticals enter into?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on September 15, 2025.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on September 22, 2025.
What is Shuttle Pharmaceuticals' state of incorporation?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware.
Where are Shuttle Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the SEC file number for Shuttle Pharmaceuticals?
The SEC file number for Shuttle Pharmaceuticals Holdings, Inc. is 001-41488.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-09-22 17:00:22
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
- $1,450,000 — he Services, the Company paid IR Agency $1,450,000. The term of the consulting agreement w
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex10-1.htm (EX-10.1) — 63KB
- ex10-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-014489.txt ( ) — 282KB
- shph-20250915.xsd (EX-101.SCH) — 3KB
- shph-20250915_lab.xml (EX-101.LAB) — 33KB
- shph-20250915_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: September 22, 2025 By: /s/ Christopher Cooper Name: Christopher Cooper Title: Interim Chief Executive Officer 3